BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Fish and Richardson
Boehringer Ingelheim
Novartis
Cerilliant
Medtronic
Federal Trade Commission
US Department of Justice
McKinsey
Farmers Insurance

Generated: January 21, 2018

DrugPatentWatch Database Preview

CHLOROMYCETIN Drug Profile

« Back to Dashboard

Which patents cover Chloromycetin, and when can generic versions of Chloromycetin launch?

Chloromycetin is a drug marketed by Parke Davis and Parkedale and is included in seven NDAs.

The generic ingredient in CHLOROMYCETIN is chloramphenicol; hydrocortisone acetate. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol; hydrocortisone acetate profile page.

US Patents and Regulatory Information for CHLOROMYCETIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis CHLOROMYCETIN chloramphenicol CREAM;TOPICAL 050183-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parkedale CHLOROMYCETIN HYDROCORTISONE chloramphenicol; hydrocortisone acetate FOR SUSPENSION;OPHTHALMIC 050202-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parkedale CHLOROMYCETIN chloramphenicol sodium succinate INJECTABLE;INJECTION 050155-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parkedale CHLOROMYCETIN chloramphenicol FOR SOLUTION;OPHTHALMIC 050143-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parke Davis CHLOROMYCETIN chloramphenicol INJECTABLE;INJECTION 050153-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parkedale CHLOROMYCETIN chloramphenicol SOLUTION/DROPS;OTIC 050205-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parkedale CHLOROMYCETIN chloramphenicol OINTMENT;OPHTHALMIC 050156-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Baxter
Queensland Health
Cantor Fitzgerald
McKinsey
Covington
Chinese Patent Office
Argus Health
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot